✦ LIBER ✦

Biosimilar recombinant human erythropoietins ("epoetins") and future erythropoiesis-stimulating treatments

✍ Scribed by Jelkmann, Wolfgang

Book ID: 115525861
Publisher: Informa plc
Year: 2012
Tongue: English
Weight: 388 KB
Volume: 12
Category: Article
ISSN: 5847-4714
DOI: 10.1517/14712598.2012.672968

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant Human Erythropoietin (rhEPO)

Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology || Epoetin treatment of anemia associated with multiple myeloma and non-Hodgkin’s lymphoma

✍ Nowrousian, Mohammad Resa 📂 Article 📅 2008 🏛 Springer Vienna ⚖ 117 KB

Sequential administration of recombinant

Sequential administration of recombinant human granulocyte-macrophage colony-stimulating factor and human erythropoietin for treatment of myelodysplasia syndromes

✍ V. Runde; C. Aul; A. Ebert; U. Grabenhorst; W. Schneider 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 664 KB

Treatment of severe aplastic anemia with

Treatment of severe aplastic anemia with an immunosuppressive agent plus recombinant human granulocyte-macrophage colony-stimulating factor and erythropoietin

✍ Zonghong Shao; Yulin Chu; Yizhi Zhang; Guibin Chen; Yizhou Zheng 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

To evaluate the therapeutic potential of hematopoietic growth factors (HGFs) during immunosuppressive treatment (IST) of severe aplastic anemia (SAA), 38 patients with newly diagnosed SAA received IST alone (group I), or IST plus recombinant human erythropoietin and granulocyte-macrophage colony-sti

Recombinant human erythropoietin at high

Recombinant human erythropoietin at high doses stimulates thrombopoiesis: Treatment for protracted severe myelosuppression complicating interferon-α and busulfan therapy for chronic myelogenous leukaemia

✍ Seiichi Kitagawa; Masaki Saito; Yasusada Miura 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

A hematological remission by clonal hema

A hematological remission by clonal hematopoiesis after treatment with recombinant human granulocyte-macrophage colony-stimulating factor and erythropoietin in a patient with therapy-related myelodysplastic syndrome

✍ Masami Bessho; Yoshihiro Itoh; Shigeru Kataumi; Nobutaka Kawai; Akira Matsuda; I 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 592 KB

Novel erythropoiesis stimulating protein

Novel erythropoiesis stimulating protein (NESP) corrects anemia in patients with chronic renal insufficiency (CRI) when administered at a reduced dose frequency relative to recombinant-human erythropoietin (rHuEPO): R Walker, F Locatelli, J Olivares, M Wilkie and the European/Australian NESP 980202 Study Group., Melbourne, Australia; Lecco, Italy; Alicante, Spain; and Sheffield, United Kingdom

📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 146 KB